1. Home
  2. PSTV vs JCSE Comparison

PSTV vs JCSE Comparison

Compare PSTV & JCSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • JCSE
  • Stock Information
  • Founded
  • PSTV 1996
  • JCSE 1999
  • Country
  • PSTV United States
  • JCSE Singapore
  • Employees
  • PSTV N/A
  • JCSE N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • JCSE Miscellaneous manufacturing industries
  • Sector
  • PSTV Health Care
  • JCSE Consumer Discretionary
  • Exchange
  • PSTV Nasdaq
  • JCSE Nasdaq
  • Market Cap
  • PSTV 7.1M
  • JCSE 7.6M
  • IPO Year
  • PSTV N/A
  • JCSE 2022
  • Fundamental
  • Price
  • PSTV $1.20
  • JCSE $1.55
  • Analyst Decision
  • PSTV Strong Buy
  • JCSE
  • Analyst Count
  • PSTV 2
  • JCSE 0
  • Target Price
  • PSTV $13.50
  • JCSE N/A
  • AVG Volume (30 Days)
  • PSTV 33.2K
  • JCSE 14.9K
  • Earning Date
  • PSTV 03-04-2025
  • JCSE 10-30-2024
  • Dividend Yield
  • PSTV N/A
  • JCSE 5.81%
  • EPS Growth
  • PSTV N/A
  • JCSE N/A
  • EPS
  • PSTV N/A
  • JCSE 0.12
  • Revenue
  • PSTV $5,725,000.00
  • JCSE $14,723,999.00
  • Revenue This Year
  • PSTV $32.12
  • JCSE N/A
  • Revenue Next Year
  • PSTV N/A
  • JCSE N/A
  • P/E Ratio
  • PSTV N/A
  • JCSE $12.55
  • Revenue Growth
  • PSTV 52.63
  • JCSE N/A
  • 52 Week Low
  • PSTV $0.93
  • JCSE $0.64
  • 52 Week High
  • PSTV $2.67
  • JCSE $2.39
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 48.71
  • JCSE 53.49
  • Support Level
  • PSTV $1.18
  • JCSE $1.42
  • Resistance Level
  • PSTV $1.30
  • JCSE $1.71
  • Average True Range (ATR)
  • PSTV 0.09
  • JCSE 0.08
  • MACD
  • PSTV -0.00
  • JCSE -0.02
  • Stochastic Oscillator
  • PSTV 45.42
  • JCSE 44.83

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment range from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. It derives a majority of its revenue from Singapore.

Share on Social Networks: